Aris Tsalouchos
Overview
Explore the profile of Aris Tsalouchos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsalouchos A, Simone G, Dattolo P, Toccafondi A, Gori G, Nesi M, et al.
J Nephrol
. 2024 Jun;
37(7):1821-1825.
PMID: 38941001
Implementing Advance Care Planning (ACP) for patients with End-Stage Kidney Disease (ESKD), particularly in the context of hemodialysis, presents significant challenges. Despite existing legal frameworks, disparities in advance care planning...
2.
Infantino M, Tsalouchos A, Russo E, Laudicina S, Grossi V, Lari B, et al.
Int J Mol Sci
. 2022 Oct;
23(20).
PMID: 36293190
The vulnerable population of kidney transplant recipients (KTRs) are low responders to COVID-19 vaccines, so specific immune surveillance is needed. The interferon-gamma (IFN-γ) release assay (IGRA) is effective in assessing...
3.
Salvadori M, Tsalouchos A
World J Nephrol
. 2022 Sep;
11(4):115-126.
PMID: 36161266
When the physiopathology of membranous nephropathy was first described, almost 30% of cases were recognized to be secondary to well-known diseases such as autoimmune diseases, tumors or infections. The remaining...
4.
Salvadori M, Tsalouchos A
World J Transplant
. 2022 Apr;
12(3):27-41.
PMID: 35433332
Due to the optimal results obtained in kidney transplantation and to the lack of interest of the industries, new innovative drugs in kidney transplantation are difficult to be encountered. The...
5.
Salvadori M, Tsalouchos A
Pediatr Nephrol
. 2021 Jul;
37(7):1431-1441.
PMID: 34244853
Podocytes are the direct target of immunologic injury in many immune-mediated glomerular diseases, leading to proteinuria and subsequent kidney failure. Immunosuppressive agents such as steroids, calcineurin inhibitors, and rituximab are...
6.
Tsalouchos A, Rossolini G, Maggi L, Mazzoni A, Annunziato F, Dattolo P
Transpl Infect Dis
. 2021 May;
23(4):e13649.
PMID: 34032340
No abstract available.
7.
Salvadori M, Tsalouchos A
World J Transplant
. 2021 Apr;
11(3):16-36.
PMID: 33816144
Aim of this frontier review has been to highlight the role of microbiota in healthy subjects and in patients affected by renal diseases with particular reference to renal transplantation. The...
8.
Salvadori M, Tsalouchos A
World J Transplant
. 2020 Sep;
10(5):90-103.
PMID: 32864355
In recent years, pharmacogenetics has emerged as an important tool for choosing the right immunosuppressant drug and its appropriate dose. Indeed, pharmacogenetics may exert its action on immunosuppressant drugs at...
9.
Salvadori M, Tsalouchos A
World J Transplant
. 2020 Aug;
10(7):191-205.
PMID: 32844095
One of the principal obstacles in transplantation from living donors is that approximately 30% are immunologically incompatible because of the presence in the recipient of antibodies directed against the human...
10.
Salvadori M, Tsalouchos A
World J Transplant
. 2019 Nov;
9(6):103-122.
PMID: 31750088
Therapeutic apheresis is a cornerstone of therapy for several conditions in transplantation medicine and is available in different technical variants. In the setting of kidney transplantation, immunological barriers such as...